Strategy

Nov 29, 2016
However conservative and heavily regulated the drugs business, it too must transform itself to exploit digital opportunities — if only to ward off disruption, says Elvis Paćelat.
Nov 11, 2016
Pharmaceutical Executive
An industry-based working group presents a common standards and definition framework for “Access” competencies in pharma.
Nov 11, 2016
Pharmaceutical Executive
Biopharma companies are increasingly leveraging product portfolios to own and dominate strategically important therapeutic areas,, writes Stan Bernard.
Nov 09, 2016
Pharmaceutical Executive
Loss of exclusivity (LOE) doesn’t have to be the death knell for branded drug revenue streams. The key approaches to preserving meaningful value well into the post-patent-loss future are outlined.
Nov 02, 2016
Dan Wetherill offers three priorities for how pharma companies can better use data analytics to engage customers.
Oct 31, 2016
Michael Gordon charts the evolution of regulatory operations and suggests how it can spearhead opportunities for innovation in pharma data.
Sep 23, 2016
The secret sauce for creating blockbuster brands has always been — and always will be — consistently exceptional team execution. Andy Mehrotra offers the recipe.
May 31, 2016
For those willing to invest in the right capabilities, offering patient services can give pharma companies a tremendous opportunity.
May 16, 2016
Payers, providers, patients and pharma companies all want to understand the value of specific treatments – and patient registries can help them do that.
May 02, 2016
As companies look to raise capital, selling and then leasing back real estate is a tempting option and one that other industries are utilizing, writes Karen Williamson.
native1_300x100
lorem ipsum